Modulation of the platelet count by Romiplostim and inhibitors of LIM kinase in genetically-engineered von Willebrand disease type 2B mice: in vivo evaluation of haemostatic efficiency. - Archive ouverte HAL Accéder directement au contenu
Poster De Conférence Année : 2018

Modulation of the platelet count by Romiplostim and inhibitors of LIM kinase in genetically-engineered von Willebrand disease type 2B mice: in vivo evaluation of haemostatic efficiency.

Mathilde Cheptou
  • Fonction : Auteur
Frédéric Adam
Olivier Christophe
Peter Lenting
Cécile Denis
Valerie Proulle
Alexandre Kauskot

Domaines

Hématologie
Fichier non déposé

Dates et versions

hal-04455308 , version 1 (13-02-2024)

Identifiants

  • HAL Id : hal-04455308 , version 1

Citer

Mathilde Cheptou, Frédéric Adam, Olivier Christophe, Peter Lenting, Cécile Denis, et al.. Modulation of the platelet count by Romiplostim and inhibitors of LIM kinase in genetically-engineered von Willebrand disease type 2B mice: in vivo evaluation of haemostatic efficiency.. ECTH, 2018, Oct 2018, Marseille, France. ⟨hal-04455308⟩
5 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More